Labcorp Holdings Inc
LH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$627.00 | Ppxyxt | Pwfstlvzyh |
Labcorp Navigates Shifting Demand From COVID-19 Tests to Non-Pandemic Tests
Business Strategy and Outlook
As a leading independent diagnostic laboratory, LabCorp participates in a highly attractive duopoly that offers bright prospects as healthcare moves toward reformed payment models, despite current Medicare headwinds.